about
COPS: a sensitive and accurate tool for detecting somatic Copy Number Alterations using short-read sequence data from paired samplesNoble metal nanoparticles applications in cancerRisk of breast and prostate cancer is not associated with increased homozygosity in outbred populationsRole of WISP-2/CCN5 in the maintenance of a differentiated and noninvasive phenotype in human breast cancer cellsEpigenetics as a mechanism driving polygenic clinical drug resistanceDefining the role of essential genes in human diseasep16(INK4a) prevents centrosome dysfunction and genomic instability in primary cells.The value of genomics in dissecting the RAS-network and in guiding therapeutics for RAS-driven cancersHZE Radiation Non-Targeted Effects on the Microenvironment That Mediate Mammary CarcinogenesisStudies of Tumor Suppressor Genes via Chromosome EngineeringPotential roles for prions and protein-only inheritance in cancerThe diagnostic value of DNA methylation in leukemia: a systematic review and meta-analysisDrugging the cancer kinome: progress and challenges in developing personalized molecular cancer therapeuticsOncogenomics and the development of new cancer therapiesBiomarkers in cancer staging, prognosis and treatment selectionSystematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancerCancer evolution and individual susceptibilityFull activity of the deleted in liver cancer 1 (DLC1) tumor suppressor depends on an LD-like motif that binds talin and focal adhesion kinase (FAK)A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer StudyClinical and molecular characterization of the BRCA2 p.Asn3124Ile variant reveals substantial evidence for pathogenic significance.Dynamics of p53 and NF-κB regulation in response to DNA damage and identification of target proteins suitable for therapeutic intervention.CHEK2 1100delC in patients with metachronous cancers of the breast and the colorectum.The BARD1 Cys557Ser variant and breast cancer risk in IcelandNew chemically induced skin tumour susceptibility loci identified in a mouse backcross between FVB and dominant resistant PWKPolymorphism Interaction Analysis (PIA): a method for investigating complex gene-gene interactions.HPD: an online integrated human pathway database enabling systems biology studies.Epstein-Barr virus-transformation of B-cell lines in ovarian cancer patients: feasibility of genomic storage for unlimited use.Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.Variation in genes required for normal mitosis and risk of breast cancerThe gene-reduction effect of chromosomal losses detected in gastric cancers.Replication of genome-wide discovered breast cancer risk loci in the Cypriot population.Mammary tumorigenesis following transgenic expression of a dominant negative CHK2 mutant.Association of the NuMA region on chromosome 11q13 with breast cancer susceptibility.Making sense of cancer genomic data.Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma.Renal cell carcinoma primary cultures maintain genomic and phenotypic profile of parental tumor tissues.Terminological mapping for high throughput comparative biology of phenotypesGenetic and clinical predictors for breast cancer risk assessment and stratification among Chinese womenA two-phase case-control study for colorectal cancer genetic susceptibility: candidate genes from chromosomal regions 9q22 and 3q22.Evaluating 17 breast cancer susceptibility loci in the Nashville breast health study.
P2860
Q21133928-E150138A-30F1-4726-9229-224F9D532122Q21284977-9B2F8044-8BCE-4C3D-A060-13D8215C9576Q24597823-D161DFBA-17B3-42F9-9D90-C179266EFAEBQ24642091-7E9ABF77-01C5-4006-8CB3-BB266F6CFAECQ24651640-F8A9E876-5715-4747-A701-1DC1267F66CBQ24810356-5BB562EA-5D7D-4C5A-9440-2894B6CB03B2Q25255634-2C32AE16-F7CB-46F1-8F63-2CF3F76352A4Q26747403-40FBB4DA-462E-49F3-A25E-E950032322ABQ26750868-E87FD3A7-AEBB-4BEE-9CAC-497ED79876DBQ26771240-8B5E9860-FF97-4E74-9C52-364C096F8DA8Q26825056-E196A48B-0303-4782-ADB2-45F33FE12C8DQ26865165-270F50D0-48C8-469E-BB5A-0EDB807F0922Q28254233-E637C17E-2217-4ACC-97AA-17E325E43820Q28263634-75B0058B-3673-459F-B759-0C3FB10B427FQ28278305-1E65EA5B-8109-4ABC-B721-0F2E8B680046Q28297342-042AA8ED-0090-44ED-9DB1-22E6C1CCB177Q28389946-687AB270-D871-4710-8A54-E036394D9A67Q28392664-4C791DBE-E10C-410B-B5E7-18C26133A5A0Q28943473-F05EBB8B-FD1E-4E42-B019-A30C5B1855F1Q30361333-8359F781-7FCA-4F36-82D2-6BBAB69D0FFAQ31090728-15803CFA-E4A8-410D-B1E1-7A8B71ACF58FQ33236605-1BED8860-17CE-41A5-B383-999484DE08DCQ33246499-A6472FED-A97F-4879-AEDB-580BAF73A721Q33289252-DBBF1FC0-B8A3-4046-AD66-6AC649096B76Q33322946-EA25CB57-C572-489B-8333-C50DB14A5EE6Q33509218-0079C906-AF20-4AEA-BE24-B1E82ADB0CAFQ33561012-3ECF0DED-9253-44C9-8F80-3B40A7C16426Q33569159-6F6BC07A-E499-46C6-BCB2-A905F7B4BA40Q33636005-26C377C6-5E6F-467E-9BD5-67EE788133E3Q33751867-7E7C0A91-A9B3-42CA-B8C4-2018678F8343Q33787026-50FC96DB-A937-4989-8988-ADABFFF10A8BQ33831941-48C1C7D6-17C4-41F0-BF95-7EF0DA1E3C1FQ33836163-C509EA47-16FB-4FEC-A368-BF573A33514AQ33846850-4C612E35-2023-487A-8D10-8550F7DA06B3Q33855801-09FA18CC-53B3-4009-97EA-27D4054F0C0BQ33931096-C47E665A-4570-4FE5-9097-9298D921D786Q33935894-019AD5E1-D0F1-4EC6-B1DC-756BE9B33F39Q33965090-026BED44-4E35-4482-B7FD-0621C04F674DQ33979369-8F633168-C31D-4D3D-9BA2-59094A9471BEQ34022151-94BB7C75-8E88-4DFE-B38C-4C447203C1E1
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
The genetics and genomics of cancer.
@ast
The genetics and genomics of cancer.
@en
The genetics and genomics of cancer.
@nl
type
label
The genetics and genomics of cancer.
@ast
The genetics and genomics of cancer.
@en
The genetics and genomics of cancer.
@nl
prefLabel
The genetics and genomics of cancer.
@ast
The genetics and genomics of cancer.
@en
The genetics and genomics of cancer.
@nl
P2093
P356
P1433
P1476
The genetics and genomics of cancer.
@en
P2093
Allan Balmain
Bruce Ponder
P2888
P304
P356
10.1038/NG1107
P407
P478
P577
2003-03-01T00:00:00Z